Jounce Therapeutics, Inc. Common Stock (JNCE)

$ 0.00
   
  • Closing Price Chg:
    $0.00
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 32.63m
  • Volume: 0
  • RiskGrade: 408

Latest ShareCast News

Jounce agrees Concentra Bioscences takeover, ditches Redx Pharma

By Michele Maatouk

Date: Monday 27 Mar 2023

(Sharecast News) - Jounce Therapeutics said on Monday that it was ditching a planned merger with AIM-listed Redx Pharma, opting instead to be bought by Concentra Bioscences.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

JNCE Market Data

Currency US Dollars
Share Price $ 0.00
Closing Price Change $ 0.00
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 32.63m
RiskGrade 408

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page